Latest News
News
Study using U.K. data quantifies infection risk associated with psoriasis
The most common serious infections were lower respiratory tract, skin and soft tissue, and upper respiratory tract infections.
News
FDA approves certolizumab label update for pregnancy, breastfeeding
Approval is based on data from the CRIB and CRADLE studies.
Latest News
FDA approves IL-23 antagonist for plaque psoriasis
Approval is based on data from two phase 3, identically designed clinical trials, reSURFACE1 and reSURFACE2.
News
Arthritis limits physical activity the most in the South
Physical inactivity rates among arthritis patients ranked highest in southern states.
News
Ultrasound study supports deep Koebner mechanism in PsA pathology
Digital accessory pulleys are thicker in PsA patients than in those with RA or psoriasis only.
Conference Coverage
PASI responses with biologics similar among white, nonwhite individuals, study finds
MIAMI– Investigators used data from psoriasis studies to determine whether treatment responses differed in skin of color patients.
Conference Coverage
Study highlights need to investigate psoriasis treatment outcomes in skin of color patients
MIAMI – Researchers used phase 2 and 3 psoriasis clinical trial data to explore potential differences in treatment response in various ethnic...
Conference Coverage
2017 was a big year for psoriatic arthritis
MAUI, HAWAII – “There is a tremendous amount of excitement now in the field of psoriatic arthritis.” – Arthur Kavanaugh, MD.
News
Xeljanz: FDA panel recommends ulcerative colitis indication
SILVER SPRING, MD. – Federal advisors to the FDA on March 8 voted unanimously to recommend approval of tofacitinib (Xeljanz) for ulcerative...
Conference Coverage
Psoriatic arthritis treatment: “We’re not doing so well”
MAUI, HAWAII – “Psoriatic arthritis lags behind rheumatoid arthritis, maybe by a decade,” despite current treatments and a treat-to-target...